The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
article
OA: gold
CC0
⤵ 1 in-corpus citation
Abstract
OBJECTIVE: Depression and anxiety are common disorders in inflammatory bowel disease (IBD). Our aim is to prospectively determine the effect of psychiatric treatment on scores for depression, anxiety, quality of life (QoL), and sexual dysfunction in an outpatient population diagnosed with IBD and also anxiety and/or depression disorder. PATIENTS AND METHODS: Patients who scored higher than the cutoff point on the Hospital Anxiety Depression Scale were referred for further structured psychiatric evaluation and determination of the need for psychiatric drug treatment. Patients who underwent drug therapy completed Short Form-36 (SF-36) and the Arizona Sexual Experience Scale at baseline and after 6 months of follow-up. RESULTS: Major depressive disorder and generalized anxiety disorder were the most common diagnoses. After 6 months, 47 patients had completely adhered to drug treatment (group A), whereas 20 were nonadherent (group B). In group A, all domains of SF-36, Arizona Sexual Experience Scale, depression/anxiety scores, and Crohn's disease activity index were statistically improved after treatment when compared with the baseline. In group B, the three domains of SF-36, platelet count, and mean corpuscular volume were worse between baseline and at 6 months. CONCLUSION: In IBD patients having any psychiatric disorder, 6 months of antidepressant drug treatment is associated with an improvement in depression, anxiety, QoL, and sexual functioning scores, as well as an improvement in Crohn's disease activity index. On the other hand, insufficient psychiatric treatment seems to be related to a poor QoL.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (1)
References (34)
- Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis via openalex
- doi:10.1097/01.psy.0000106907.24881.f2 via openalex
- doi:10.1176/appi.psy.51.3.208 via openalex
- W2037377025 via openalex
- doi:10.1002/ibd.21346 via openalex
- doi:10.1053/j.gastro.2007.09.001 via openalex
- doi:10.1046/j.1365-2036.2002.01323.x via openalex
- doi:10.1097/00054725-200608000-00005 via openalex
- doi:10.1007/s00535-012-0700-2 via openalex
- doi:10.1111/apt.12669 via openalex
- doi:10.1007/s00384-014-1962-3 via openalex
- W6683985687 via openalex
- doi:10.1159/000437299 via openalex
- doi:10.1002/ibd.20873 via openalex
- doi:10.3748/wjg.v20.i13.3552 via openalex
- doi:10.1053/j.gastro.2008.09.012 via openalex
- doi:10.1097/jcp.0b013e3181fc343b via openalex
- doi:10.1111/j.1600-0447.1983.tb09716.x via openalex
- doi:10.1111/j.1572-0241.2008.01980.x via openalex
- doi:10.1097/00004836-200101000-00015 via openalex
- doi:10.1080/009262300278623 via openalex
- doi:10.1016/0163-8343(96)00036-9 via openalex
- doi:10.1016/j.crohns.2013.09.002 via openalex
- doi:10.1016/s0033-3182(10)70687-3 via openalex
- doi:10.5455/jmood.20140228012738 via openalex
- doi:10.1038/sj.ijir.3901249 via openalex
- doi:10.1056/nejm198712243172603 via openalex
- doi:10.1097/01.mib.0000179468.78876.2d via openalex
- doi:10.1016/0016-5085(79)90384-6 via openalex
- doi:10.1016/j.medcli.2008.07.002 via openalex
- doi:10.1002/ibd.20520 via openalex
- doi:10.1001/archinte.160.14.2101 via openalex
- doi:10.1002/ibd.21846 via openalex
- doi:10.1016/j.jpsychores.2011.06.006 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T06:24:00.257642+00:00
License: CC0
· commercial use OK